Gene · 4595
Papers3,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 3,741
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-Gene Mutation Profiling by Targeted Next-Generation Sequencing in Premenopausal Breast Cancer. | Genes (Basel) | 2022 | 36011273 | PubTator, text mining | PubMed |
| Mutational and splicing landscape in a cohort of 43,000 patients tested for hereditary cancer. | NPJ Genom Med | 2022 | 36008414 | PubTator, text mining | PubMed |
| Gender differences in pancreatic neuroendocrine neoplasms: A retrospective study based on the population of Hubei Province, China. | Front Endocrinol (Lausanne) | 2022 | 36004340 | PubTator, text mining | PubMed |
| Double heterozygous pathogenic variants prevalence in a cohort of patients with hereditary breast cancer. | Front Oncol | 2022 | 36003761 | PubTator, text mining | PubMed |
| A case of early onset adenocarcinoma associated with colorectal polyposis with an unknown germline mutation. | Surg Case Rep | 2022 | 36002671 | PubTator, text mining | PubMed |
| The role of methylation profiling in histologically diagnosed neurocytoma: a case series. | J Neurooncol | 2022 | 35994156 | PubTator, text mining | PubMed |
| Optimizing the Personalized Care for the Management of Rectal Cancer: A Consensus Statement. | Turk J Gastroenterol | 2022 | 35993526 | PubTator, text mining | PubMed |
| DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms. | Oncologist | 2022 | 35983951 | PubTator, text mining | PubMed |
| Case Report: A rare case of familial lung cancer requiring pneumonectomy in three male siblings. | Front Oncol | 2022 | 35982978 | PubTator, text mining | PubMed |
| GeneHome - a Novel Model to Deliver Care to Individuals with Genetic Predisposition to Cancer. | Cancer Control | 2022 | 35976772 | PubTator, text mining | PubMed |
| Chromothripsis is a frequent event and underlies typical genetic changes in early T-cell precursor lymphoblastic leukemia in adults. | Leukemia | 2022 | 35974102 | PubTator, text mining | PubMed |
| Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients. | Genome Med | 2022 | 35971132 | PubTator, text mining | PubMed |
| Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer. | Nat Med | 2022 | 35970919 | PubTator, text mining | PubMed |
Identifying Patients Who Meet Criteria for Genetic Testing of Hereditary Cancers Based on Structured and Unstructured Family Health History Data in the Electronic Health Record: Natural Language Processing Approach. | JMIR Med Inform | 2022 | 35969459 | PubTator, text mining | PubMed |
| Development and Validation of the PREMMplus Model for Multigene Hereditary Cancer Risk Assessment. | J Clin Oncol | 2022 | 35960913 | PubTator, text mining | PubMed |
| Hereditary Breast Cancer in the Brazilian State of Ceará (The CHANCE Cohort): Higher-Than-Expected Prevalence of Recurrent Germline Pathogenic Variants. | Front Oncol | 2022 | 35957908 | PubTator, text mining | PubMed |
| Routine Immunohistochemical Analysis of Mismatch Repair Proteins in Colorectal Cancer-A Prospective Analysis. | Cancers (Basel) | 2022 | 35954394 | PubTator, text mining | PubMed |
| Extracellular Nucleic Acids in the Diagnosis and Progression of Colorectal Cancer. | Cancers (Basel) | 2022 | 35954375 | PubTator, text mining | PubMed |
| Evaluation of a Patient With Non-Myoinvasive Uterine Serous Carcinoma Confined to a Polyp and Positive Peritoneal Washings With Somatic ARHGAP35 and KRAS Mutations. | Cureus | 2022 | 35949786 | PubTator, text mining | PubMed |
| Substitution mutational signatures in whole-genome-sequenced cancers in the UK population. | Science | 2022 | 35949260 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4595/papers?page=40